CAS 99697-24-2
:(3R)-3-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl]butansäure
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
24-Norursodeoxycholic acid
CAS:24-Norursodeoxycholic acid (nor-UDCA) is a Ursodeoxycholic Acid derivative. It has potent anti-inflammatory, anti-cholestatic, and anti-fibrotic properties.Formel:C23H38O4Reinheit:99.69%Farbe und Form:White SolidMolekulargewicht:378.545424-Norursodeoxycholic acid
CAS:24-Norursodeoxycholic acidFormel:C23H38O4Reinheit:99.5%Molekulargewicht:378.55(3α,5β,7β)-3,7-Dihydroxy-24-norcholan-23-oic acid
CAS:Formel:C23H38O4Reinheit:97%Farbe und Form:SolidMolekulargewicht:378.545424-Nor Ursodeoxycholic Acid
CAS:Kontrolliertes ProduktApplications Ursodeoxycholic Acid (U850000) derivative. 24-norUrsodeoxycholic acid is superior to Ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
References Seedorf, U., et al.: J. Biol. Chem., 269, 21277 (1994), Stolowich, N., et al.: Biochemistry, 36, 1719 (1997),Formel:C23H38O4Farbe und Form:NeatMolekulargewicht:378.5524-Nor Ursodeoxycholic Acid-d5
CAS:Kontrolliertes ProduktApplications Labelled Ursodeoxycholic Acid (U850000) derivative. 24-norUrsodeoxycholic acid is superior to Ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
References Seedorf, U., et al.: J. Biol. Chem., 269, 21277 (1994), Stolowich, N., et al.: Biochemistry, 36, 1719 (1997),Formel:C23D5H33O4Farbe und Form:NeatMolekulargewicht:383.576(R)-3-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)butanoic acid
CAS:Formel:C23H38O4Reinheit:97%Molekulargewicht:378.5524-Norursodeoxycholic acid
CAS:Kontrolliertes Produkt24-Norursodeoxycholic acid is a synthetic bile acid derivative, which is a modified form derived from natural bile acids. Its primary source is the chemical synthesis of ursodeoxycholic acid analogs. The mode of action involves modulating bile acid composition within the liver, thereby reducing cytotoxicity associated with bile acid accumulation. This modulation helps protect hepatocytes from damage, reducing liver inflammation and fibrosis.
Formel:C23H38O4Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:378.55 g/mol







